378 related articles for article (PubMed ID: 24152761)
1. Herpes simplex virus drug-resistance: new mutations and insights.
Andrei G; Snoeck R
Curr Opin Infect Dis; 2013 Dec; 26(6):551-60. PubMed ID: 24152761
[TBL] [Abstract][Full Text] [Related]
2. Frequency of acyclovir-resistant herpes simplex viruses isolated from the general immunocompetent population and patients with acquired immunodeficiency syndrome.
Ziyaeyan M; Alborzi A; Japoni A; Kadivar M; Davarpanah MA; Pourabbas B; Abassian A
Int J Dermatol; 2007 Dec; 46(12):1263-6. PubMed ID: 18173520
[TBL] [Abstract][Full Text] [Related]
3. Survey of acyclovir-resistant herpes simplex virus in the Netherlands: prevalence and characterization.
Stránská R; Schuurman R; Nienhuis E; Goedegebuure IW; Polman M; Weel JF; Wertheim-Van Dillen PM; Berkhout RJ; van Loon AM
J Clin Virol; 2005 Jan; 32(1):7-18. PubMed ID: 15572000
[TBL] [Abstract][Full Text] [Related]
4. Genotypic and phenotypic characterization of acyclovir-resistant herpes simplex viruses isolated from haematopoietic stem cell transplant recipients.
Stránská R; van Loon AM; Polman M; Beersma MF; Bredius RG; Lankester AC; Meijer E; Schuurman R
Antivir Ther; 2004 Aug; 9(4):565-75. PubMed ID: 15456088
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic and genotypic characterization of acyclovir-resistant corneal HSV-1 isolates from immunocompetent patients with recurrent herpetic keratitis.
Burrel S; Boutolleau D; Azar G; Doan S; Deback C; Cochereau I; Agut H; Gabison EE
J Clin Virol; 2013 Sep; 58(1):321-4. PubMed ID: 23731845
[TBL] [Abstract][Full Text] [Related]
6. Resistance of herpes simplex virus infections to nucleoside analogues in HIV-infected patients.
Levin MJ; Bacon TH; Leary JJ
Clin Infect Dis; 2004 Nov; 39 Suppl 5():S248-57. PubMed ID: 15494896
[TBL] [Abstract][Full Text] [Related]
7. Antiviral resistance in herpes simplex virus and varicella-zoster virus infections: diagnosis and management.
Piret J; Boivin G
Curr Opin Infect Dis; 2016 Dec; 29(6):654-662. PubMed ID: 27306564
[TBL] [Abstract][Full Text] [Related]
8. [Antiviral drug therapy of infections caused by Herpes simplex and Varicella Zoster viruses].
Vogt M; Huss R; Wunderli W
Schweiz Med Wochenschr; 1992 Apr; 122(16):569-75. PubMed ID: 1579862
[TBL] [Abstract][Full Text] [Related]
9. Beta interferon plus gamma interferon efficiently reduces acyclovir-resistant herpes simplex virus infection in mice in a T-cell-independent manner.
Huang WY; Su YH; Yao HW; Ling P; Tung YY; Chen SH; Wang X; Chen SH
J Gen Virol; 2010 Mar; 91(Pt 3):591-8. PubMed ID: 19906941
[TBL] [Abstract][Full Text] [Related]
10. Acyclovir prophylaxis predisposes to antiviral-resistant recurrent herpetic keratitis.
van Velzen M; van de Vijver DA; van Loenen FB; Osterhaus AD; Remeijer L; Verjans GM
J Infect Dis; 2013 Nov; 208(9):1359-65. PubMed ID: 23901090
[TBL] [Abstract][Full Text] [Related]
11. Novel resistance-associated mutations of thymidine kinase and DNA polymerase genes of herpes simplex virus type 1 and type 2.
Sauerbrei A; Bohn K; Heim A; Hofmann J; Weissbrich B; Schnitzler P; Hoffmann D; Zell R; Jahn G; Wutzler P; Hamprecht K
Antivir Ther; 2011; 16(8):1297-308. PubMed ID: 22155911
[TBL] [Abstract][Full Text] [Related]
12. Herpes simplex virus resistance to acyclovir: clinical relevance.
Pottage JC; Kessler HA
Infect Agents Dis; 1995 Sep; 4(3):115-24. PubMed ID: 8548189
[TBL] [Abstract][Full Text] [Related]
13. Resistance of herpes simplex viruses to acyclovir: an update from a ten-year survey in France.
Frobert E; Burrel S; Ducastelle-Lepretre S; Billaud G; Ader F; Casalegno JS; Nave V; Boutolleau D; Michallet M; Lina B; Morfin F
Antiviral Res; 2014 Nov; 111():36-41. PubMed ID: 25218782
[TBL] [Abstract][Full Text] [Related]
14. Latent acyclovir-resistant herpes simplex virus type 1 in trigeminal ganglia of immunocompetent individuals.
van Velzen M; van Loenen FB; Meesters RJ; de Graaf M; Remeijer L; Luider TM; Osterhaus AD; Verjans GM
J Infect Dis; 2012 May; 205(10):1539-43. PubMed ID: 22457282
[TBL] [Abstract][Full Text] [Related]
15. Surveillance of herpes simplex virus resistance to antivirals: a 4-year survey.
Burrel S; Aime C; Hermet L; Ait-Arkoub Z; Agut H; Boutolleau D
Antiviral Res; 2013 Nov; 100(2):365-72. PubMed ID: 24075863
[TBL] [Abstract][Full Text] [Related]
16. Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years' experience with acyclovir.
Tyring SK; Baker D; Snowden W
J Infect Dis; 2002 Oct; 186 Suppl 1():S40-6. PubMed ID: 12353186
[TBL] [Abstract][Full Text] [Related]
17. Profiling penciclovir susceptibility and prevalence of resistance of herpes simplex virus isolates across eleven clinical trials.
Sarisky RT; Bacon TH; Boon RJ; Duffy KE; Esser KM; Leary J; Locke LA; Nguyen TT; Quail MR; Saltzman R
Arch Virol; 2003 Sep; 148(9):1757-69. PubMed ID: 14505088
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic and genotypic acyclovir resistance surveillance of genital herpes simplex virus 2 in South Africa.
Muller EE; Maseko DV; Kularatne RS
Antiviral Res; 2022 Apr; 200():105277. PubMed ID: 35271913
[TBL] [Abstract][Full Text] [Related]
19. Antiviral agents for herpes simplex virus.
Vere Hodge RA; Field HJ
Adv Pharmacol; 2013; 67():1-38. PubMed ID: 23885997
[TBL] [Abstract][Full Text] [Related]
20. [Virostatic treatment of herpes simplex infections of variable severity].
Raab R; Söltz-Szöts J
Hautarzt; 1990 Aug; 41(8):413-5. PubMed ID: 2272824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
